(enrofloxacin/silver sulfadiazine) Antibacterial-Antimycotic Emulsion
Baytril® Otic is indicated as a treatment for canine otitis externa complicated by bacterial and fungal organisms susceptible to enrofloxacin and/or silver sulfadiazine.
The use of Baytril® Otic in pets with perforated tympanic membranes has not been evaluated. Therefore, the integrity of the tympanic membrane should be evaluated before administering this product. If hearing or vestibular dysfunction is noted during the course of treatment, discontinue use of Baytril® Otic. Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation which may lead to convulsive seizures. Quinolone-class drugs have been associated with cartilage erosions in weightbearing joints and other forms of arthropathy in immature animals of various species. The safe use of Baytril® Otic in dogs used for breeding purposes, during pregnancy, or in lactating bitches, has not been evaluated.
DOSAGE AND ADMINISTRATION:
Shake well before each use.
Tilt head so that the affected ear is presented in an upward orientation. Administer a sufficient quantity of
Baytril® Otic to coat the aural lesions and the external auditory canal. As a general guide, administer 5-10 drops
per treatment in dogs weighing 35 lbs. or less and 10-15 drops per treatment in dogs weighing more than 35 lbs.
Following treatment, gently massage the ear so as to ensure complete and uniform distribution of the
medication throughout the external ear canal. Apply twice daily for a duration of up to 14 days.
TOXICITY AND SAFETY:
In a target animal safety study, Baytril® Otic was administered in both ears of 24 clinically normal beagle dogs at either recommended or exaggerated dosages: 10, 30 or 50 drops applied twice daily for 42 consecutive days. A control group of 8 beagle dogs was treated by administering 50 drops of vehicle in one ear twice daily for 42 consecutive days, with the contralateral ear untreated. Erythema was noted in all groups, including both treated and untreated ears in the controls, which resolved following termination of treatment. .
Federal (USA) Law restricts this drug to use by or on the order of a licensed veterinarian. For use in animals only. In rare instances, use of this product in cats has been associated with Retinal Toxicity. Do not exceed 5 mg/kg of body weight per day in cats. Safety in breeding or pregnant cats has not been established. Keep out of reach of children.
Store between 4° and 25°C (40 - 77°F). Store in an upright position. Do not store in direct sunlight..